跳至主要内容
临床试验/ChiCTR1800014626
ChiCTR1800014626进行中(未招募)不适用

子宮腺肌症對不孕及體外受精之影響

No1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 1990年1月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
50
试验地点
1
主要终点
evaluate the overall incidence of adenomyosis in patient undergoing IVF treatment

研究概览

简要总结

研究子宮腺肌症對不孕及體外受精之影響

研究设计

研究类型
病因学/相关因素研究
主要目的
单臂

入排标准

年龄范围
18 至 45(—)
性别
Female

入选标准

  • aged 18 to 45 years old;
  • a diagnosis of clinically suspected and ultrasound/MRI diagnosis adenomyosis undergoing ART treatment.

排除标准

  • previous uterine surgery;
  • uterine malformation;
  • endometrial abnormalities like those with endometrial polyps, fibroids;
  • refuse to join.

研究组 & 干预措施

Case series

No

干预措施: No

结局指标

主要结局

evaluate the overall incidence of adenomyosis in patient undergoing IVF treatment

时间窗: (1) & (2): ultrasound/ MRI and hysteroscopy will be performed by individual schedule, (3) Endometrial sampling: LH surge + 7 days

explore the relationship between adenomyosis and recurrent implantation failure.

时间窗: (1) & (2): ultrasound/ MRI and hysteroscopy will be performed by individual schedule, (3) Endometrial sampling: LH surge + 7 days

次要结局

  • evaluate the IVF stimulation, laboratory and reproductive outcome of those patients with adenomyosis, especially in those with recurrent implantation failure.((1) At the time of recruitment, (2) ultrasound/ MRI will be performed by individual schedule)

研究者

发起方
No

研究点 (1)

Loading locations...

相似试验